Update on CARMENA trial: Cytoreductive nephrectomy in metastatic renal cancer wi...
Prof Arnaud Mejean - Paris Descartes University, Paris, France
3 Jun 2019
Biomarker analysis from JAVELIN Renal 101: Avelumab plus axitinib versus sunitin...
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
1 Jun 2019
KEYNOTE-062 study: Pembrolizumab as treatment for advanced gastroesophageal junc...
Dr Josep Tabernero - Vall d’Hebron Barcelona University Hospital, Barcelona, Spa...
1 Jun 2019
Comment: Reasonable to conclude that pembrolizumab is non-inferior to chemothera...
Dr Richard Schilsky and Dr Josep Tabernero
1 Jun 2019
Pembrolizumab comparable to chemotherapy for patients with advanced gastric or g...
Dr Josep Tabernero - Vall d’Hebron Barcelona University Hospital , Barcelona, Sp...
1 Jun 2019
IMPACT: Improving Management of Advanced Colorectal Tumours
Mr Steve Clark, Patient Advocate for Bowel Cancer UK and Expert Patient for ACPG...
21 May 2019
Pre-operative radiation for pancreatic cancer
Prof Sunil Krishnan - MD Anderson Cancer Center, Houston, USA
9 May 2019
Second-line and beyond in mCRC: Optimising the benefit and reducing the risk
Prof Mohamed Salem - Georgetown University Hospital, Washington D.C., USA
9 May 2019
Optimum duration of adjuvant treatment of stage III colorectal cancer: 3 versus ...
Prof John Marshall - Georgetown University Hospital, Washington D.C., USA
9 May 2019
Colorectal cancer in the young: What do we know and what can we do?
Prof John Marshall - Georgetown University Hospital, Washington D.C., USA
9 May 2019
Rectal cancers: Positioning of watchful waiting and minimally invasive procedure...
Prof Henk Wegstapel - Canterbury Christ Church University, Canterbury, UK
9 May 2019
Beyond second-line therapy: New hope for mCRC patients in Egypt
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
9 May 2019
